Key Metrics
CiteScore 

13.6
Eigenfactor 

0.01 - 0.05
Impact Factor 

5 - 10
SJR 

Q1Biotechnology

SNIP 

1.19
Recommended pre-submission checks
Powered by 

Topics Covered on Artificial Cells, Nanomedicine and Biotechnology
Artificial Cells, Nanomedicine and Biotechnology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | GBP 2085 |
| Publication Time | 20 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Artificial Cells, Nanomedicine and Biotechnology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Artificial Cells, Nanomedicine and Biotechnology
Detection of pathogenic novel intronic splicing variants in the KIDINS220 gene causes motor developmental delay
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Advancing bone tissue engineering: anisotropic performance of poly(lactic-co-glycolic acid) (PLGA) composites with nano-calcium sulphate (nCS) and fucoidan (fu)
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Prefrontal cortex-extracellular vesicle RNAs coupling in alcohol use disorder: towards non-invasive biomarkers and targeted therapeutics
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Cross-talk between diabetic nephropathy and bone loss: PBMCs-guided discovery of NLRP3-inflammatory signalling
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
The mechanism of Gei Herba against type 2 diabetes mellitus: an integration of gut microbiota and network pharmacology analysis
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Bio-Inspired lipid nanovesicles (iNVs) incorporating membrane proteins from healthy tendon stem cells for targeted protein restoration in tendinopathic in vitro model
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Detection of pathogenic novel intronic splicing variants in the KIDINS220 gene causes motor developmental delay
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Advancing bone tissue engineering: anisotropic performance of poly(lactic-co-glycolic acid) (PLGA) composites with nano-calcium sulphate (nCS) and fucoidan (fu)
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Prefrontal cortex-extracellular vesicle RNAs coupling in alcohol use disorder: towards non-invasive biomarkers and targeted therapeutics
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Cross-talk between diabetic nephropathy and bone loss: PBMCs-guided discovery of NLRP3-inflammatory signalling
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
The mechanism of Gei Herba against type 2 diabetes mellitus: an integration of gut microbiota and network pharmacology analysis
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Bio-Inspired lipid nanovesicles (iNVs) incorporating membrane proteins from healthy tendon stem cells for targeted protein restoration in tendinopathic in vitro model
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology